Sex, lies and heart failure. Conceptual mistakes in classification and epidemiology

Italian Heart Journal

Volumn 6, Issue 1, 2005, Pages 66-72

  Martínez Sellés, Manuel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; CONGESTIVE HEART FAILURE; HEALTH; HEART CONTRACTION; HEART STROKE VOLUME; HUMAN; INCIDENCE; INTERPERSONAL COMMUNICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RECUMBENCY; REVIEW; SEX DIFFERENCE; SURVIVAL RATE;

DECEPTION; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MYOCARDIAL CONTRACTION; PREVALENCE; SEX FACTORS; STROKE VOLUME; SURVIVAL RATE; TRUTH DISCLOSURE; WORLD HEALTH;

EID: 19844371814     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Yamani M, Massie BM. Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin Proc 1993; 68: 1214-8.
2. McDermott MM, Feinglass J, Lee PI, et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 1997; 134: 728-36.
3. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137: 352-60.
4. Khand AU, Gemmell I, Rankin AC, Cleland JG. Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. Eur Heart J 2001; 22: 153-64.
5. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993; 14: 1158-62.
6. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99-104.
7. Martínez-Sellés M, García-Robles JA, Prieto L, et al. Annual rates of admission and seasonal variations in hospitalizations for heart failure. Eur J Heart Fail 2002; 4: 779-86.
8. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJ. Failure of women's hearts. Circulation 1999; 99: 2334-41.
9. McMurray J. Heart failure: we need more trials in typical patients. Eur Heart J 2000; 21: 699-700.
10. Lindenfeld J, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol 1997; 30: 1417-9.
11. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15.
12. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-6.
13. Adams KF Jr, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28: 1781-8.
14. Adams KF Jr, Sueta CA, Gheorghiade M, et al. Gender differences in survival in advanced heart failure: insights from the FIRST study. Circulation 1999; 99: 1816-21.
15. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001; 103: 375-80.
16. Ghali JK, Pina IL, Gottlieb SS, et al, on behalf of the MERIT-HF Study Group. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002; 105: 1585-91.
17. Burns RB, McCarthy EP, Moskowitz MA, Ash A, Kane RL, Finch M. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997; 45: 276-80.
18. Vaccarino V, Chen YT, Wang Y, Radford MJ, Krumholz HM. Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am Heart J 1999; 138 (Part 1): 835-42.
19. Martínez-Sellés M, García-Robles JA, Prieto L, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J 2003; 24: 2046-53.
20. Ghali JK, Krause-Steinrauf HJ, Adams KF, et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 2003; 42: 2128-34.
21. Martínez-Sellés M, Domínguez M, García-Fernández MA, García E. Women with severely depressed left ventricular ejection fraction have less right ventricular dysfunction than men. (abstr) Eur J Echocardiogr 2004; 5: S92.
22. Ibrahim SA, Burant CJ, Kent Kwoh C. Elderly hospitalized patients with diastolic heart failure: lack of gender and ethnic differences in 18-month mortality rates. J Gerontol A Biol Sci Med Sci 2003; 58: 56-9.
23. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628-37.
24. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 1999; 20: 421-8.
25. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 1972; 287: 781-7.
26. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34.
27. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121 (Part 1): 951-7.
28. Sharpe N. Management principles: much more to be gained. In: Sharpe N, ed. Heart failure management. London: Martin Dunitz, 2000: 15-28.
29. Martínez-Sellés M, García-Robles JA, Muñoz R, et al. Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur J Heart Fail 2004; 6: 219-26.
30. Martínez-Sellés M, Bueno H. Manejo de la insuficiencia cardíaca del anciano. ¿Quién y donde? Revista Española de Geriatría y Gerontología 2002; 37: 13-9.
31. Martínez-Sellés M, García Robles JA, Prieto L, et al. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function. Rev Esp Cardiol 2002; 55: 579-86.
32. Reis SE, Holubkov R, Edmundowicz D, et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol 1997; 30: 733-8.
33. Philbin EF, Weil HF, Erb TA, Jenkins PL. Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. Chest 1999; 116: 346-54.
34. McDonald K, Ledwidge M, Cahill J, et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge. Eur J Heart Fail 2001; 3: 209-15.
35. Zanolla L, Zardini P. Selection of endpoints for heart failure clinical trials. Eur J Heart Fail 2003; 5: 717-23.
36. Teerlink JR. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J 2003; 145 (Suppl): S26-S33.
37. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001; 7: 176-82.
38. Martínez-Sellés M. The OPTIMAAL trial: losartan or captopril after acute myocardial infarction. (letter) Lancet 2002; 360: 1885.
39. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990; 322: 1635-41.
40. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends and incidence and survival in a 10-year period. Arch Intern Med 1999; 159: 29-34.
41. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948-55.
42. Martínez-Sellés M, García-Robles JA, Prieto L, et al. Heart failure in the elderly: age related differences in clinical profile and mortality. Int J Cardiol, in press.
43. Aronow WS, Ahn C, Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 1998; 113: 867-9.
44. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997; 45: 968-74.
45. Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344: 17-22.
46. Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function: clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996; 156: 146-57.
47. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-74.
48. Mosterd A. Heart failure in the population at large; news from the real world. Eur Heart J 1999; 20: 398-9.
49. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ 2000; 321: 215-8.
50. Burkhoff D, Maurer MS, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 2003; 107: 656-8.
51. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714-20.
52. Wilhelmsen L, Eriksson H, Svardsudd K, Caidahl K. Improving the detection and diagnosis of congestive heart failure. Eur Heart J 1989; 10 (Suppl C): 13-8.
53. Criteria Committee. New York Heart Association Inc. Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis. 6th edition. Boston, MA: Little Brown, 1964: 114.
54. Chakko SC, Gheorghiade M. Estimating severity of chronic heart failure: a clinical challenge for the 1990s. Am Heart J 1992; 124: 260-4.
55. Lipkin P, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986; 292: 653-5.
56. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993; 71: 1106-7.
57. Remme WJ, Swedberg K, on behalf of the Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
58. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70: 359-63.
59. Massie BM. Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure. Good news and bad. J Am Coll Cardiol 2003; 41: 2018-21.
60. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107: 2545-7.
61. Martínez-Sellés M. B-type natriuretic peptide in the evaluation of acute dyspnea. (letter) N Engl J Med 2004; 350: 2416-7.
62. Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure. Good to go in 2004? J Am Coll Cardiol 2004; 44: 740-9.